BACKGROUND: Determination of arsenic species in saliva is potentially useful for biomonitoring of human exposure and studying arsenic metabolism. Arsenic speciation in saliva has not been reported previously.
METHODS:
We separated arsenic species in saliva using liquid chromatography (LC) and quantified them by inductively coupled plasma mass spectrometry. We further confirmed the identities of arsenic species by LC coupled with electrospray ionization tandem mass spectrometry. These methods were successfully applied to the determination of arsenite (As 
, in Ͼ300 saliva samples collected from people who were exposed to varying concentrations of arsenic.
RESULTS:
The mean (range) concentrations (g/L) in the saliva samples from 32 volunteers exposed to background levels of arsenic were As III 0.3 [not detectable (ND) to 0.7], As V 0.3 (ND to 0.5), MMA V 0.1 (ND to 0.2), and DMA V 0.7 (ND to 2.6). Samples from 301 people exposed to increased concentrations of arsenic in drinking water showed detectable As III in 99%, As V in 98%, MMA V in 80%, and DMA V in 68% of samples. The mean (range) concentrations of arsenic species in these saliva samples were (in g/L) As III 2.8 (0.1-38), As V 8.1 (0.3-120), MMA V 0.8 (0.1-6.0), and DMA V 0.4 (0.1-3.9). Saliva arsenic correlated with drinking water arsenic. Odds ratios for skin lesions increased with saliva arsenic concentrations. The association between saliva arsenic concentrations and the prevalence of skin lesions was statistically significant (P Ͻ0.001). Biomonitoring of chemicals and their metabolites in the human body is an important area of investigation (1 ) . Arsenic in saliva, which may indicate the concentrations of arsenic in the body, may serve as a new biomarker for studying arsenic exposure and metabolism. Salivary glands have high blood flow, and chemicals and their metabolites are distributed in saliva by several mechanisms, including passive diffusion, active transport, and ultrafiltration (2 ) . Previous studies on the use of saliva for biomonitoring have focused on herbicide (3 ), insecticide (4, 5) , lead (6, 7) , cadmium (7 ), phthalate (8 ) , and drug (9 ) concentrations in humans or animal models. The concentrations of chemical contaminants in saliva have been shown to reflect their concentrations in plasma (4 ). Saliva sampling is noninvasive and has advantages over urine collection, particularly from young children still in diapers (7, 9) .
Studying arsenic species in saliva may increase our understanding of arsenic exposure, metabolism, and toxicity. Many studies on metabolism and toxicity of arsenic have relied on the analyses of biological fluids, including urine, blood, bile, and breast milk (10 -20 ) . No reports describe the detection of arsenic species in human saliva, however, although many chemical contaminants are metabolized and excreted to saliva (21 ) .
A major challenge for detection of chemical contaminants in saliva is that the concentrations of the chemical contaminants are usually very low, often 1 to 2 orders of magnitude lower than in blood (4, 5) . To achieve the sensitivity necessary for the detection of arsenic in saliva and to identify the arsenic species at ultratrace concentrations, we developed 2 highly specific techniques. We used inductively coupled plasma mass spectrometry (ICP-MS) 5 to detect arsenic species after separation by liquid chromatography (LC) and then applied electrospray tandem mass spectrometry (ESI-MS/MS) (16, 22 ) with multiplereaction monitoring (MRM) to confirm the identification of arsenic species.
Materials and Methods

INSTRUMENTS AND REAGENTS
The instruments used in the study included an MDS SCIEX Applied Biosystems 4000Q-Trap MS/MS analyzer equipped with an electrospray ion-source, an Agilent 7500cs octopole reaction system ICP-MS, operated with the helium mode, and an Agilent 1100 series liquid chromatograph, equipped with an autosampler and column temperature control. Chromatographic separation was achieved with a Phenomenex reversedphase ODS-3 column (150 ϫ 4.6 mm, 3-m particle size) and a Hamilton PRP-X100 strong anion exchange column (150 ϫ 4.1 mm) or a Hamilton PRP-X200 strong cation exchange column (150 ϫ 4.1 mm).
We purchased arsenite (As III ), arsenate (As V ), and dimethylarsinic acid (DMA V ) from Aldrich and of monomethylarsonic acid (MMA V ) from Chem Service and prepared stock solutions (1000 mg/L) from these materials. We prepared working solutions by appropriate dilutions of the above stock solutions with deionized water. MMA III standard was prepared from the solid oxide (CH 3 AsO) and DMA III from the iodide [(CH 3 ) 2 AsI]. The precursors were prepared according to reported procedures (23 ) and were stored at 4°C or Ϫ20°C. Diluted solutions of the precursors were prepared fresh in deionized water. For quality control, we purchased the standard reference materials SRM1640 (Trace Elements in Natural Water) and SRM2670 (Trace Elements in Urine) from NIST. We used tetrabutylammonium hydroxide (Aldrich), malonic acid (Fisher), methanol (Fisher), and ammonium bicarbonate (Sigma) for preparation of the mobile-phase solutions, which were filtered through a 0.45-m membrane before use for LC separation.
SALIVA COLLECTION
This study was conducted according to the recommendations of the World Medical Association Declaration of Helsinki (24 ) for international health research. All participants gave written informed consent.
A saliva sample was collected from each of 32 volunteers (15 men and 17 women, age range 25 to 45 years) living in Edmonton, Canada. The concentration of arsenic in drinking water was Ͻ5 g/L. Saliva was also collected from 301 people living in Ba Men, Inner Mongolia, China, where the concentrations of arsenic in drinking water (ground water) are as high as 826 g/L. Demographic information on the participants has been reported for another biomarker study in the same population (25 ) . The samples were collected at least 1 h after any food consumption; and before collection, participants rinsed their mouths at least 3 times to remove any food residue. The study participants provided saliva samples by spitting into 50-mL polyethylene centrifuge tubes. The samples were transported on dry ice via air courier and were stored at Ϫ20°C until analysis.
PRETREATMENT OF SALIVA FOR ARSENIC SPECIATION
The frozen saliva samples were thawed at room temperature and thoroughly vortex-mixed. We diluted the saliva 3-fold by pipetting 500 L saliva and 1 mL deionized water into a 15-mL centrifuge tube. After vortexmixing and ultrasonication, the dilute sample was filtered through a 0.45-m filter immediately before LC analysis.
DIGESTION OF SALIVA FOR TOTAL ARSENIC
We pipetted 300 L saliva and 1.0 mL concentrated nitric acid into a 5-mL glass vial. The mixture was then heated at 60°C for 12 h. The acid in the sample was evaporated by heating at 80°C until approximately 100 L of the solution remained. The sample was finally diluted to 1.5 mL with deionized water and analyzed for total arsenic by ICP-MS.
QUANTIFICATION OF ARSENIC SPECIES BY LC-ICP-MS
We carried out ion pair separation by use of the Phenomenex ODS-3 reversed-phase column with a mobile phase containing 5 mmol/L tetrabutylammonium, 5% methanol, and 3 mmol/L malonic acid (pH 5.6), with a flow rate of 1.2 mL/min. The column temperature was controlled at 48°C. As III , As V , DMA V , MMA V , DMA III , and MMA III were separated in approximately 5 min. The eluent from the LC column was directly introduced to the inlet of the ICP nebulizer using polytetrafluoroethylene tubing and appropriate fittings (26 ) . The ICP was operated at a radio frequency power of 1550 W. The flow rate of argon carrier gas was 0.8 L/min. Helium (3.6 mL/min) was used as the collision gas for the octopole reaction mode to reduce isobaric and polyatomic interference.
IDENTIFICATION OF ARSENIC SPECIES BY BOTH LC-ESI-MS/MS AND LC-ICP-MS
Initially, we operated ESI-MS/MS in the enhanced MS scan mode, in 1:1 methanol/water solution, to obtain MS/MS spectra of the arsenic species. The optimization of operating conditions was carried out using 200 g/L standard solutions of each arsenic species. The pH values of the MMA V and DMA V solutions were adjusted to 2.0 -3.0 using formic acid, and MMA V and DMA V were monitored under the positive ionization mode. The optimal electrospray conditions were: curtain gas (N 2 ) 1.1 L/min, ionspray voltage 5000 V, temperature 300°C, declustering potential 30 V, collision energy 30 V, and cell exit potential 26 V. As III and As V were monitored using the negative ionization mode, and the pH values of the As III and As V standard solutions was adjusted to 8.0 -10. The optimal ionspray parameter settings for As III and As V were curtain gas (N 2 ) 1.8 L/min, ionspray voltage Ϫ4500 V, temperature 300°C, and collision energy Ϫ20 V. The declustering potential was Ϫ100 V for As III and Ϫ130 V for As V . Because the mobile phase for the ion-pair chromatography was not compatible with ESI-MS/MS, a strong anion exchange column was used to separate arsenic species. The arsenic species were subsequently detected using both ICP-MS and ESI-MS/MS. Ammonium bicarbonate (20 mmol/L, pH 8.5) was used as the mobile phase at a flow rate of 0.8 mL/min. The LC effluent was split equally for ICP-MS and ESI-MS/MS detection. The flow to the ICP-MS was directly introduced to the nebulizer of ICP-MS. The flow to the ESI-MS/MS was mixed with a solution containing methanol and either formic acid or ammonium hydroxide. 
DETERMINATION OF TOTAL ARSENIC BY FLOW INJECTION
ICP-MS
We analyzed the acid-digested saliva samples for total arsenic using flow-injection ICP-MS. A 50 -100 L sample was injected into a carrier stream of water at a flow rate of 1 mL/min, and was introduced to the ICP-MS.
Results
SEPARATION AND IDENTIFICATION OF ARSENIC SPECIES USING LC WITH ICP-MS AND ESI-MS/MS DETECTION
Using ion-pair chromatography, we achieved the separation of 6 arsenic species, including As III , As
, and MMA III , in approximately 5 min. Speciation of saliva samples and samples enriched with arsenic species showed matching retention times for chromatographic peaks in saliva and the standards.
To confirm the identity of arsenic species in the samples, we further complemented the ICP-MS detection with ESI-MS/MS. Whereas ICP-MS provided detection of elemental arsenic (at m/z 75), ESI-MS/MS offered molecular information characteristic to each of the arsenic species. Therefore, we were able to achieve identification and quantification of arsenic species by using LC separation with both ICP-MS and ESI-MS/MS detection, as described below.
To Fig. 1 shows ion chromatography separation with ICP-MS monitoring of As at m/z 75 ( Fig. 1a and 1b) , MRM for DMA V transitions 139/91 (Fig. 1c) and 139/121 (Fig. 1d) , and MRM for MMA V transitions 141/93 (Fig. 1e ) and 141/123 (Fig. 1f) . The matching of chromatographic retention times between the saliva sample (Fig. 1b) and arsenic standard solution (Fig. 1a) suggests the presence of As III , DMA V , MMA V , and As V in the saliva sample. MRM monitoring of DMA V transitions at m/z 139/91 (Fig. 1c ) and 139/121 (Fig. 1d) supports that the 2nd peak (3.8 min) is indeed DMA V . Likewise, the specific MRM of MMA V transition at m/z 141/93 (Fig. 1e ) and 141/123 (Fig. 1f) supports the identity of MMA V (15.0 min) in the saliva sample. Fig. 2 shows separation of arsenic in another saliva sample with ICP-MS detection of arsenic species (Fig. 2a) , MRM monitoring for As III transitions at m/z 107/91 (Fig. 2b) and 125/107 (Fig. 2c) , and MRM monitoring for a specific As V transition at m/z 141/123 (Fig. 2d) . Retention times of the peaks detected by both ICP-MS (Fig. 2a) and ESI-MS/MS (Fig. 2b-d ) match those of standards As III and As V (Fig. 1a) . Cation exchange separation was also performed on selected samples to confirm the presence of As III and As V in the saliva sample.
DETERMINATION OF SALIVA ARSENIC CONCENTRATIONS
Having identified As III , As V , MMA V , and DMA V species in saliva, we further quantified the concentrations of these arsenic species in saliva samples from volunteers (Table 1) and from a group of people who were exposed to varying concentrations of arsenic in drink- 
. Chromatograms from LC-ICP-MS and LC-ESI-MS/MS analysis of arsenic in a standard solution (a) and in a saliva sample (b-f ).
An anion exchange column (Hamilton PRP-X100, 150 ϫ 4.6 mm, 5-m particle size) was used to separate the arsenic species. The mobile phase contained 20 mmol/L ammonium bicarbonate and 5% methanol at pH 8. ing water (Table 2 ). Speciation analyses of saliva samples from 32 volunteers showed that As The saliva samples from Inner Mongolia showed higher concentrations of arsenic ( Table 2 ). The total arsenic concentrations ranged from 0.4 to 140 g/L. The major arsenic species were inorganic As III and As V , accounting for 85% of total arsenic. Most of the samples (98%-99%) contained detectable As III and As V , 
. Chromatograms from LC-ICP-MS (a) and LC-ESI-MS/MS (b-d ) analyses of a saliva sample.
The chromatographic conditions were the same as in Fig. 1 
80% of samples had detectable MMA
V , and 68% of samples had detectable DMA V . The mean percentages of individual arsenic species concentration over the mean total arsenic concentration were: As III 28%, As V 57%, MMA V 7%, and DMA V 4%. In addition, an unknown arsenic species was present in 20% of the samples and accounted for approximately 13% of total arsenic concentration in the saliva samples. The retention time (5.3 min) of this species was longer than that of As V and did not match that of any arsenic species available to us, including the 4 arsenic species shown in Fig. 1 (27) (28) (29) . We confirmed no retention time match between the unknown and the above arsenic species, using 3 chromatography systems: ion-pair chromatography (13 ) , strong anion exchange ( Figs. 1 and 2) , and strong cation exchange (PRP-X200 column with 5 mmol/L pyridine and 5% methanol as mobile phase, pH 2.9). In addition, we used LC-ESI-MS/MS to analyze the saliva sample containing the unknown species. The ion transitions did not match those of our arsenic standards. The exact composition of the unknown arsenic species remains to be characterized.
Five samples had a detectable peak retention time identical to that of MMA III , and 3 samples had a peak retention time matching that of DMA III . Because of the low concentration and the insufficient sample volume, however, we were not able to use MRM to confirm their identity in the saliva samples.
STANDARD REFERENCE MATERIALS
In the absence of standard reference material (SRM) for saliva arsenic, we analyzed Natural Water 1640 and 2 urine SRMs (SRM 2670 and CRM no. 18) (11, 13 ) . Eleven repeat speciation analyses of Natural Water 1640 using LC-ICP-MS showed that the mean (SD) concentrations of As III and As V were 0.76 (0.05) g/L 
LIMITS OF DETECTION
With the LC-ICP-MS method, the limits of detection, defined as the concentration of arsenic that produced a chromatographic peak having intensity equal to 3 times the SD of the baseline noise ( 
RECOVERY AND COMPARISON BETWEEN THE SUM OF ARSENIC SPECIES AND TOTAL ARSENIC CONCENTRATIONS
To evaluate the possible effect of the saliva sample matrix on the separation and quantification of arsenicals, we measured recovery using the saliva samples from the volunteers separately enriched with each arsenic species. The enriched concentrations were 0.5-50 g/L for As III and As V and 0.5-5 g/L for the methylated arsenic species. The recoveries of As III , As V , DMA V , and MMA V were 98%-100%. The recoveries of MMA III and DMA III were 82%-97%. The saliva sample matrix did not affect the separation of arsenic species, as shown by the identical retention times between arsenic standards and saliva samples ( Figs. 1 and 2 ).
Each saliva sample was separately analyzed for individual arsenic species and for total arsenic concentrations. Results in Tables 1 and 2 show that the sum of arsenic species concentrations (obtained from LC-ICP-MS and LC-ESI-MS/MS) was in good agreement with the total arsenic concentrations (obtained from ICP-MS analyses without LC separation).
CORRELATION BETWEEN SALIVA ARSENIC SPECIES AND SKIN
LESIONS
To evaluate the relationship between the presence of skin lesions and saliva arsenic concentrations, saliva arsenic measures were log (base 10) transformed and categorized into quartiles, and the adjusted odds ratios were calculated using logistic regression models. Table  3 summarizes the adjusted odds ratios for skin lesions by quartiles of arsenic concentrations. For all 4 arsenic species, with the increase of their concentrations in saliva, the number of people with skin lesions in- creases and the odds ratio for skin lesions also increases. The highest odds ratio (8.545) for skin lesions is associated with the highest quartile of As III concentration in saliva. Odds ratios for skin lesions associated with the highest quartiles of As V , MMA V , and DMA V concentrations were 3.246, 3.396, and 5.595, respectively. These associations were statistically significant (P Ͻ0.001).
Discussion
Before this study, no data had been reported on arsenic concentration or speciation in human saliva. This report is the first to describe the detection of arsenic species in saliva and show the evidence of methyl arsenical metabolites, MMA V and DMA V , as well as inorganic As III and As V in saliva. The detection and identification of trace arsenic species in saliva are possible because of the coupling of highly sensitive and selective analytical techniques (LC-ICP-MS and LC-ESI-MS/MS). LC-ICP-MS enables selective quantification of arsenic species, and LC-ESI-MS/MS provides confirmation of the species identities. The mass spectra of arsenic species obtained in our experiment are in agreement with those previously obtained using a single quadrupole mass spectrometer (22 ) .
Statistical analysis clearly showed that the prevalence of skin lesions increased with increasing concentrations of saliva arsenic species (Table 3) . For example, among those with the lowest quartile of As III concentrations, the prevalence of skin lesions was 9.8%, but this increased to 39.2% among those in the highest quartile (adjusted odds ratio ϭ 8.545, P ϭ 0). Similarly, the odds ratios for skin lesions increase with the concentrations of As V , MMA V , and DMA V (Table 3) . For all saliva measures the trend with the prevalence of skin lesions was significant (P ϭ 0.0001). Skin lesions are an important clinical symptom of chronic arsenic exposure and poisoning. The good correlation between the saliva arsenic concentration and the prevalence of skin lesions suggests that saliva arsenic can be a useful biomarker. Furthermore, correlation coefficients between arsenic species in saliva and total arsenic in drinking water were As III 0.470, As V 0.589, MMA V 0.663, and DMA V 0.485 (P Ͻ0.001 for all). Arsenic in drinking water is mostly in inorganic forms, As V and As III (31) (32) (33) (34) (35) . Various organic arsenic species are present in food (34 -35 ) . The presence of MMA V and DMA V in saliva samples suggests direct absorption of these arsenic species or methylation of inorganic arsenic (34 -37 ) . During this biomethylation process, monomethylarsonous acid (MMA III ) and dimethylarsinous acid (DMA III ) can be formed as intermediates (13, 14, 36, 37 ) . These trivalent methylarsenic species are more toxic than the pentavalent arsenic species (36 -40 ) . A few saliva samples showed detectable peaks matching those of MMA III and DMA III standards by LC-ICP-MS analysis; however, we were not able to provide confirmation by ESI-MS/MS analysis because of the limited sample volume and very low concentrations of these species.
In conclusion, inorganic arsenicals and their methylation metabolites, MMA V and DMA V , were quantified in saliva samples collected from people who were exposed to various concentrations of arsenic. The ability to quantify the individual arsenic species and the noninvasive collection of saliva samples make arsenic speciation in saliva a potentially useful biomonitoring approach for assessing human exposure to arsenic. 
